UK's NHS "constitution" dismissed by patients' group

26 January 2009

The UK's Patients Association has dismissed the signing of a "constitution" for the National Health Service as a largely meaningless  exercise, because it is no more than an aspirational document, with no  proper sanctions for non-compliance or resources available to implement  it. The concept is a main plank of the reforms to the  government-managed health care system.

Among the alleged "rights" available to patients under the new  document's provisions are: "a new legal right to receive the  vaccinations that the Joint Committee on Vaccination and Immunization  recommends," which previously was the case; "a right making explicit  [the patient's] entitlement to drugs and treatments that have been  recommended by [the National Institute for Health and Clinical  Excellence (NICE)]...if your doctor says they are clinically  appropriate for you," which is potentially more restrictive than  previous arrangements; and "a right to expect local decisions on funding  of other drugs and treatments to be made rationally following a proper  consideration of the evidence;" which has been enforced by the courts  already (Marketletters passim).

"No penalties for failure"

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight